Agape Atp Corporation Asset Turnover Ratio (ATPC), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Agape Atp Corporation  (NASDAQ: ATPC)
 

Agape Atp Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Agape Atp's asset turnover ratio sequentially decreased to 0.05 in the second quarter (Jun 30 2026), this is lower than usual.

Within sector 166 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 77 to 3230.

Asset Turnover Ratio Definition



ATPC Asset Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Asset Change 2.3 % -1.01 % 656.48 % 513.87 % 477.65 %
Y / Y Revenue Change -76.56 % -5.32 % 10.94 % 11.86 % 48.7 %
Asset Turnover Ratio (TTM) 0.05 0.06 0.06 0.08 0.1
ATPC's Total Ranking # 3230 # 77 # 3043 # 3156 # 2883
Seq. Asset Change 1.47 % 1.34 % 0.85 % -1.35 % -1.81 %
Seq. Revenue Change -60.13 % -31.44 % 7.7 % -20.39 % 61.05 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 167
Healthcare Sector # 502
Overall Market # 3230

Asset Turnover Ratio Statistics
High Average Low
0.33 0.12 0.05
(Dec 31 2024)   (Jun 30 2026)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Nektar Therapeutics  0.09 $ 54.589  Millions$ 610.038  Millions
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Catheter Precision Inc   0.07 $ 1.915  Millions$ 28.322  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions
Caribou Biosciences Inc   0.06 $ 10.035  Millions$ 165.531  Millions
Ispecimen inc   0.06 $ 0.466  Millions$ 8.133  Millions
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Mangoceuticals Inc   0.02 $ 0.315  Millions$ 15.311  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Alumis inc   0.01 $ 7.398  Millions$ 533.040  Millions
Vyne Therapeutics Inc   0.01 $ 0.430  Millions$ 31.089  Millions
Vivosim Labs Inc   0.01 $ 0.112  Millions$ 8.892  Millions
Envoy Medical Inc   0.01 $ 0.207  Millions$ 17.628  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 1.809  Millions$ 171.835  Millions
Sharps Technology Inc   0.01 $ 2.468  Millions$ 263.597  Millions
Clene Inc   0.01 $ 0.197  Millions$ 21.287  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.